[Event] 8th Annual Summit on Life Sciences IP Due Diligence

Or call 1-888-224-2480 for fastest service.

Save 10% off* the current registration fee by using code D10-999-JDS26

Attend ACI's 8th Annual Summit on Life Sciences IP Due Diligence, and join IP counsel from across the life sciences industry to benchmark your diligence strategies, strengthen portfolio valuation approaches, and stay ahead of evolving policy and regulatory developments.

This conference is the one-stop shop for all Life Sciences IP Due Diligence stakeholders to keep checklists robust, deals profitable, and understand how the latest legal, regulatory, and policy developments are impacting IP due diligence reviews in the bio-pharma industries.

Distinguished Chairs:

Attend and learn from esteemed speakers from such leading companies as Novartis, Invidior, Orna Therapeutics, Novo Nordisk who will help you:

• Revamp your IP due diligence checklist to evaluate policy-related risk in furtherance of a deal
• Anticipate how the potential use of march-in rights may impact IP ownership assessment in your diligence review
• Factor IP developments in the EU and Asia into your life sciences IP due diligence review
• Integrate review of trade secrets and policy into your due diligence
• Focus on AI: Keeping clear of data provenance dangers in a diligence review

Save 10% off* the current registration fee by using code D10-999-JDS26

*Discount is valid for new registrations only and it’s not applicable for workshops.